|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,250,000,000 |
Market
Cap: |
91.01(B) |
Last
Volume: |
18,277,023 |
Avg
Vol: |
12,077,193 |
52
Week Range: |
$40.25 - $64.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 97 |
Guru Rank Value : 8.6 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
Total People Sold |
0 |
0 |
2 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
11 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2016-01-03 |
4 |
D |
$68.79 |
$23,389 |
D/D |
(340) |
52,672 |
|
- |
|
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2016-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
53,012 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-12-31 |
4 |
A |
$68.79 |
$53,106 |
D/D |
772 |
333,624 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-12-15 |
4 |
AS |
$70.05 |
$812,580 |
D/D |
(11,600) |
332,852 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-12-14 |
4 |
AS |
$67.99 |
$788,843 |
D/D |
(11,600) |
344,452 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-11-20 |
4 |
AS |
$67.76 |
$786,016 |
D/D |
(11,600) |
501,052 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-11-19 |
4 |
AS |
$67.01 |
$777,470 |
D/D |
(11,600) |
512,652 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
45,000 |
456,052 |
|
- |
|
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2015-11-01 |
4 |
D |
$65.75 |
$14,728 |
D/D |
(224) |
52,062 |
|
- |
|
Elicker John E |
SVP Pub Affairs & Inv Relation |
|
2015-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
496 |
52,286 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-11-01 |
4 |
D |
$65.75 |
$91,787 |
D/D |
(1,396) |
162,561 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
163,957 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-10-06 |
4 |
AS |
$58.89 |
$692,904 |
D/D |
(11,600) |
524,252 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-10-05 |
4 |
AS |
$61.84 |
$719,027 |
D/D |
(11,600) |
535,852 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-09-30 |
4 |
A |
$59.20 |
$34,218 |
D/D |
578 |
547,452 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-09-03 |
4 |
AS |
$59.13 |
$691,032 |
D/D |
(11,600) |
546,874 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-09-02 |
4 |
AS |
$58.60 |
$687,005 |
D/D |
(11,600) |
558,474 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-08-03 |
4 |
S |
$64.75 |
$20,589,328 |
D/D |
(315,000) |
570,074 |
|
- |
|
Andreotti Lamberto |
Director |
|
2015-08-03 |
4 |
OE |
$22.73 |
$7,561,950 |
D/D |
315,000 |
885,074 |
|
- |
|
Blin Emmanuel |
SVP, Head of Commercialization |
|
2015-07-02 |
4 |
D |
$67.48 |
$14,778 |
D/D |
(219) |
734 |
|
- |
|
Blin Emmanuel |
SVP, Head of Commercialization |
|
2015-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
951 |
953 |
|
- |
|
Gordon Murdo |
SVP, Head of Worldwide Markets |
|
2015-07-01 |
4 |
D |
$67.67 |
$81,948 |
D/D |
(1,211) |
1,329 |
|
- |
|
Gordon Murdo |
SVP, Head of Worldwide Markets |
|
2015-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,335 |
2,540 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2015-06-04 |
4 |
S |
$65.70 |
$1,115,229 |
D/D |
(16,972) |
59,284 |
|
- |
|
Blin Emmanuel |
SVP, Head of Commercialization |
|
2015-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1 |
|
- |
|
953 Records found
|
|
Page 31 of 39 |
|
|